Literature DB >> 11331958

Transcriptional activation of p21 by vitamin D(3) or vitamin K(2) leads to differentiation of p53-deficient MG-63 osteosarcoma cells.

M Zenmyo1, S Komiya, T Hamada, K Hiraoka, S Kato, T Fujii, H Yano, K Irie, K Nagata.   

Abstract

p21 (WAF1/CIP1) is a downstream effector of p53 and mediates growth arrest by inhibiting the action of G(1) cyclin-dependent kinases. However, it has been reported that the p21 expression was triggered by multiple differentiation-inducing agents by a p53-independent pathway. These agents induced expression of p21 by binding to specific DNA elements and modulating transcriptional initiation. We demonstrated that the gene encoding p21 was not only a vitamin D(3) target gene but also a vitamin K(2) target gene in the cells and that their differentiation was well related to the transcriptional activation of the p21 gene. Transient overexpression of p21, using adenovirus-driven p21 expression plasmid, in MG-63 cells in the absence of vitamins D(3) and K(2) resulted in their differentiation. The transcriptional activation of p21 by vitamin D(3) or vitamin K(2) in p53-deficient osteosarcoma cells demonstrated the p53-independent role of p21 in human osseous differentiation. HUM PATHOL 32:410-416. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331958     DOI: 10.1053/hupa.2001.23524

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

1.  Molecular basis of differentiation therapy for soft tissue sarcomas.

Authors:  Gaurav Luther; Richard Rames; Eric R Wagner; Gaohui Zhu; Qing Luo; Yang Bi; Stephanie H Kim; Jian-Li Gao; Enyi Huang; Ke Yang; Linyuan Wang; Xing Liu; Mi Li; Ning Hu; Yuxi Su; Xiaoji Luo; Liang Chen; Jinyong Luo; Rex C Haydon; Hue H Luu; Lan Zhou; Tong-Chuan He
Journal:  Trends Cancer Res       Date:  2010

Review 2.  Osteosarcoma development and stem cell differentiation.

Authors:  Ni Tang; Wen-Xin Song; Jinyong Luo; Rex C Haydon; Tong-Chuan He
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

3.  1alpha,25-Dihydroxyvitamin D(3) antiproliferative actions involve vitamin D receptor-mediated activation of MAPK pathways and AP-1/p21(waf1) upregulation in human osteosarcoma.

Authors:  Wei Wu; Xiaoyu Zhang; Laura P Zanello
Journal:  Cancer Lett       Date:  2007-04-06       Impact factor: 8.679

4.  The Current and Future Therapies for Human Osteosarcoma.

Authors:  Joseph D Lamplot; Sahitya Denduluri; Jiaqiang Qin; Ruidong Li; Xing Liu; Hongyu Zhang; Xiang Chen; Ning Wang; Abdullah Pratt; Wei Shui; Xiaoji Luo; Guoxin Nan; Zhong-Liang Deng; Jinyong Luo; Rex C Haydon; Tong-Chuan He; Hue H Luu
Journal:  Curr Cancer Ther Rev       Date:  2013-02

5.  Defective osteogenic differentiation in the development of osteosarcoma.

Authors:  Eric R Wagner; Gaurav Luther; Gaohui Zhu; Qing Luo; Qiong Shi; Stephanie H Kim; Jian-Li Gao; Enyi Huang; Yanhong Gao; Ke Yang; Linyuan Wang; Chad Teven; Xiaoji Luo; Xing Liu; Mi Li; Ning Hu; Yuxi Su; Yang Bi; Bai-Cheng He; Ni Tang; Jinyong Luo; Liang Chen; Guowei Zuo; Richard Rames; Rex C Haydon; Hue H Luu; Tong-Chuan He
Journal:  Sarcoma       Date:  2011-02-22

6.  Hyperoside, a flavonoid compound, inhibits proliferation and stimulates osteogenic differentiation of human osteosarcoma cells.

Authors:  Ning Zhang; Mei-Dan Ying; Yong-Ping Wu; Zhi-Hong Zhou; Zhao-Ming Ye; Hang Li; Ding-Sheng Lin
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

Review 7.  Vitamin K: Redox-modulation, prevention of mitochondrial dysfunction and anticancer effect.

Authors:  Donika Ivanova; Zhivko Zhelev; Plamen Getsov; Biliana Nikolova; Ichio Aoki; Tatsuya Higashi; Rumiana Bakalova
Journal:  Redox Biol       Date:  2018-03-20       Impact factor: 11.799

8.  PLK2 modulation of enriched TAp73 affects osteogenic differentiation and prognosis in human osteosarcoma.

Authors:  Wenhu Li; Xianliao Zhang; Xinhua Xi; Yufa Li; Hong Quan; Shifeng Liu; Liqi Wu; Penghuan Wu; Wenxing Lan; Yongjun Shao; Haomiao Li; Kebing Chen; Zhengbo Hu
Journal:  Cancer Med       Date:  2020-04-29       Impact factor: 4.452

9.  Endocrine disruption of vitamin D activity by perfluoro-octanoic acid (PFOA).

Authors:  Andrea Di Nisio; Maria Santa Rocca; Luca De Toni; Iva Sabovic; Diego Guidolin; Stefano Dall'Acqua; Laura Acquasaliente; Vincenzo De Filippis; Mario Plebani; Carlo Foresta
Journal:  Sci Rep       Date:  2020-10-08       Impact factor: 4.379

10.  p73 is essential for vitamin D-mediated osteoblastic differentiation.

Authors:  R Kommagani; A Whitlatch; M K Leonard; M P Kadakia
Journal:  Cell Death Differ       Date:  2009-09-25       Impact factor: 15.828

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.